| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/25/2005 | US20050186628 Dorsalin-1 polypeptide and uses thereof |
| 08/25/2005 | US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 08/25/2005 | US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186571 Diagnosis and prevention of cancer cell invasion |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 08/25/2005 | US20050186559 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease |
| 08/25/2005 | US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same |
| 08/25/2005 | US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 08/25/2005 | US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor |
| 08/25/2005 | US20050186195 Structural or functional components of the creatine kinase/ phosphocreatine system sufficient to prevent, reduce or ameliorate skin damage or skin aging; psoriasis |
| 08/25/2005 | US20050186194 Structural or functional components of the creatine kinase/ phosphocreatine system sufficient to prevent, reduce or ameliorate skin damage or skin aging; psoriasis |
| 08/25/2005 | US20050186158 Use of creatine or creatine compounds for skin preservation |
| 08/25/2005 | US20050186148 Prophylaxis or treatment of dental caries, dental plaque, and periodontal infection that include lactic bacteria that are not part of the resident microflora of the mouth, are low acidifying, and are capable of adhering directly to the pellicle of the teeth |
| 08/25/2005 | DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy |
| 08/25/2005 | CA2556404A1 Nitrogenous fused heteroaromatic ring derivative |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566440A2 Human Interleukin-11 Receptor |
| 08/24/2005 | EP1566384A1 Novel azole derivatives |
| 08/24/2005 | EP1566380A1 Isoquinoline compounds and medicinal use thereof |
| 08/24/2005 | EP1566379A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 08/24/2005 | EP1566184A1 Remedy for corneal failure |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1566178A1 Remedy for fibromyalgia |
| 08/24/2005 | EP1566175A1 Topical preparation comprising at least one aryloxime and bisabolol |
| 08/24/2005 | EP1566174A2 Flash-melt oral dosage formulation |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565172A2 Suppression of cytotoxic protein conformers |
| 08/24/2005 | EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 08/24/2005 | EP1478770A4 Screening method for orthopoxvirus antivirals |
| 08/24/2005 | EP1468003B1 Phosphinic pseudo-peptide derivatives |
| 08/24/2005 | EP1458713B1 Indolinone derivatives useful as protein kinase inhibitors |
| 08/24/2005 | EP1402008B1 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
| 08/24/2005 | EP1334085B1 Sulfamides as gamma-secretase inhibitors |
| 08/24/2005 | EP1330435B1 Crystalline forms of fluvastatin sodium |
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1276749B1 Photo-labile coumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | EP1242085B1 Benzimidazole compounds having nociceptin receptor affinity |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | EP1190248B1 Screening methods for compounds which affect melanogenesis |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1143925B1 Topical composition comprising n-acetylglucosamine |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP1072266B1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | CN1659436A Method for isolating ligands |
| 08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 08/24/2005 | CN1659183A Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases |
| 08/24/2005 | CN1659170A Thienyl compounds |
| 08/24/2005 | CN1659168A Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/24/2005 | CN1659165A Quinolinone derivatives |
| 08/24/2005 | CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1659162A Tricyclic thrombin receptor antagonists |
| 08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
| 08/24/2005 | CN1659156A Novel guanidinobenzamides |
| 08/24/2005 | CN1659154A Method of preparing amine stereoisomers |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 08/24/2005 | CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 08/24/2005 | CN1659136A Novel sodium channel blockers |
| 08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1659130A Induction of apoptosis in cancer cells |
| 08/24/2005 | CN1658905A Modified byrodin 1 with reduced immunogenicity |
| 08/24/2005 | CN1658904A Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/24/2005 | CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658898A Orodispersible pharmaceutical composition comprising perindopril |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658881A Anti-inflammatory compositions and methods of use |
| 08/24/2005 | CN1658880A Combination therapy for the treatment of cancer |
| 08/24/2005 | CN1658879A Neurotrophic factor production accelerator |
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658864A Stabilized ascorbic acid derivatives |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |